Surgepays (SURG) Stock Price
Surgepays Price
Over the last 18 years Surgepays grew revenue by 65.8% annually, reaching 56.96 M USD. Earnings per share have grown at 26.1% per year over the last 9 years. For Surgepays, the net margin of -63.3% is down versus -26.5% a few years ago.
Surgepays stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Surgepays business model & stock analysis
Frequently asked questions about Surgepays
7 analysts currently rate the Surgepays stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Surgepays to generate revenue of 64.90 M USD and earnings per share of -0.40 USD.
Converted at the current exchange rate, the Surgepays share trades at 0.11 EUR (0.12 USD).
The expected revenue of Surgepays is 64.90 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Surgepays is -8.41 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Surgepays is currently -0.30. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Surgepays stock.
The price-to-sales ratio (P/S) of Surgepays is currently 0.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Surgepays stock.
The Eulerpool Quality Score for Surgepays is 2/10.
The ISIN of Surgepays is US86882L2043. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Surgepays is SURG. The ticker symbol is used to trade Surgepays shares on the stock exchange.
Surgepays stock
All fundamentals and in-depth analysis of Surgepays
Our stock analysis for Surgepays stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgepays. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.